Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Mitomycin C

3

II.b ARDS - Acute lung injury

2
Last update : 31/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC.
World journal of surgical oncology 2017 Feb 20;15;49 2017 Feb 20
Intravesical mitomycin-C-induced interstitial pneumonia.
Respiration; international review of thoracic diseases 2010;80;256-9 2010
Mitomycin lung toxicity. Acute and chronic phases.
American journal of clinical oncology 1997 Jun;20;282-4 1997 Jun
A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Cancer 1986 Oct 01;58;1428-36 1986 Oct 01
Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma.
Archives of internal medicine 1985 Oct;145;1905-7 1985 Oct
Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C.
American journal of clinical oncology 1984 Dec;7;719-24 1984 Dec
Pulmonary toxicity of mitomycin.
Cancer 1980 Jan 15;45;236-44 1980 Jan 15
Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
Cancer 1979 May;43;1598-603 1979 May

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies